U.S. Luxury Stock News

NasdaqGS:POWL
NasdaqGS:POWLElectrical

Powell Industries Coverage Highlights Acquisition Valuation Concerns And Recent Momentum

Powell Industries (NasdaqGS:POWL) has received initial coverage from Cantor Fitzgerald, focusing on the recent acquisition of Remsdaq. The acquisition is intended to expand the company’s automation and software capabilities within its existing operations. Powell Industries has also updated its executive compensation structure, indicating an internal response to its ongoing corporate plans. For investors watching Powell Industries at a current share price of $423.44, these moves follow a...
NYSE:DGX
NYSE:DGXHealthcare

Is It Time To Reassess Quest Diagnostics (DGX) After Its Mixed Recent Share Price Moves

If you are wondering whether Quest Diagnostics at around US$182 per share is offering fair value right now, you are not alone. The answer depends on which valuation lens you use. The stock has seen mixed recent returns, with a 3.7% decline over the last 7 days, a 3.7% gain over the last 30 days, a 5.0% return year to date, and a 16.2% return over the past year, alongside 33.0% and 51.0% returns over 3 and 5 years respectively. Recent headlines around Quest Diagnostics have focused on its...
OTCPK:VXRT
OTCPK:VXRTBiotechs

Does Vaxart’s (VXRT) Early Norovirus Infant Data Hint At A Broader Oral Vaccine Platform Advantage?

Vaxart, Inc. recently reported in npj Vaccines that its double-blind, placebo-controlled Phase 1 trial of a single-dose oral bivalent norovirus vaccine in breastfeeding women showed vaccine-induced functional norovirus-specific antibodies in maternal breastmilk and serum, as well as norovirus-specific IgA in the stool of their breastfed infants, with the vaccine remaining safe and well tolerated. The finding of a positive correlation between breast milk IgA levels and infant stool IgA offers...
NasdaqGM:CZWI
NasdaqGM:CZWIBanks

Citizens Community Bancorp (CZWI) Net Margin Strengthens And Supports Bullish Earnings Narratives

Citizens Community Bancorp (CZWI) just capped FY 2025 with fourth quarter revenue of US$15.6 million and EPS of US$0.44, while trailing 12 month revenue stood at US$60.4 million and EPS at US$1.46. Over recent periods, quarterly revenue has ranged from US$14.4 million to US$15.6 million and quarterly EPS from roughly US$0.32 to US$0.44, giving investors a clear view of how the earnings run rate has evolved into the current trailing 12 month profile. With net profit margins holding in the mid...
NYSE:MMM
NYSE:MMMIndustrials

Is It Time To Reassess 3M (MMM) After Legal Settlements And DCF Valuation Gap

If you are wondering whether 3M's current share price really reflects its underlying worth, this article walks through the key numbers so you can judge the value story for yourself. 3M's share price last closed at US$159.52, with returns of 4.9% decline over 7 days, 1.6% decline over 30 days, 1.4% decline year to date, 7.3% over 1 year, 89.5% over 3 years and 31.3% over 5 years. These figures give useful context for any valuation check you are considering. Recent news around 3M has focused...
NYSE:FBP
NYSE:FBPBanks

First BanCorp Dividend Hike Highlights Undervalued Share Price And Income Appeal

First BanCorp (NYSE:FBP) has announced an 11% increase in its quarterly cash dividend. The change reflects the bank's current financial position and focus on returning cash to shareholders. This dividend adjustment is a material event for income focused investors tracking the stock. First BanCorp, a financial services company operating under the NYSE:FBP ticker, is closely watched by investors who care about income and capital stability. Dividend moves often draw attention because they...
NasdaqGM:ARDX
NasdaqGM:ARDXBiotechs

Is It Too Late To Consider Ardelyx (ARDX) After The Recent Share Price Surge?

If you are wondering whether Ardelyx shares still offer value at around US$7.80, you are not alone. The recent price action has put the stock firmly on many watchlists. The share price sits at US$7.80 after returns of 15.6% over 7 days, 35.9% over 30 days, 26.8% year to date, 42.6% over 1 year and a very large gain over 3 years, with 12.1% over 5 years also adding context. Recent headlines around Ardelyx have focused on its position in the pharmaceuticals and biotech space and ongoing...
OTCPK:FFBB
OTCPK:FFBBBanks

FFB Bancorp (OTCPK:FFBB) Margin Compression Challenges Bullish Valuation Narrative After FY 2025 Results

FFB Bancorp (FFBB) just wrapped up FY 2025 with fourth quarter revenue of US$19.4 million and basic EPS of US$1.08, setting the tone for how the full year is being assessed. Over recent quarters, revenue has moved from US$26.6 million in Q4 2024 to US$27.3 million in Q1 2025, US$24.2 million in Q2 2025 and US$22.8 million in Q3 2025, while quarterly EPS shifted from US$3.06 to US$2.56, US$1.95 and US$2.07 across the same stretch. Taken together with the latest trailing 12 month totals, these...
NasdaqGS:UBSI
NasdaqGS:UBSIBanks

United Bankshares Record 2025 Earnings Highlight Scale And Capital Return

United Bankshares (NasdaqGS:UBSI) reported record earnings for 2025, supported by its acquisition of Piedmont Bancorp. The company completed the integration of Piedmont Bancorp, adding to its banking footprint and customer base. United Bankshares also finished a substantial share repurchase program, signaling a focus on returning capital to shareholders. United Bankshares operates as a regional banking group, providing lending, deposit, and related financial services to consumers and...
NasdaqGM:PEBK
NasdaqGM:PEBKBanks

Peoples Bancorp Of North Carolina (PEBK) Margin Gain And 21.3% Earnings Growth Reinforce Bullish Narratives

Peoples Bancorp of North Carolina (PEBK) just closed out FY 2025 with fourth quarter revenue of US$24.6 million and EPS of US$1.25, alongside trailing 12 month revenue of US$89.1 million and EPS of US$3.74 that reflects 21.3% earnings growth over the past year. Over recent periods, the company has seen quarterly revenue move from US$21.1 million in Q4 2024 to US$24.6 million in Q4 2025, while quarterly EPS shifted from US$0.67 to US$1.25. This sets up a story where improving margins and a...
NasdaqCM:USAU
NasdaqCM:USAUMetals and Mining

U.S. Gold (USAU) Is Up 9.8% After $31M CK Financing And Feasibility Progress - Has The Bull Case Changed?

U.S. Gold Corp recently advanced its CK Gold Project in Wyoming toward a Definitive Feasibility Study after securing US$31,000,000 in financing, while benefiting from record-high gold prices that enhance project economics and the perceived value of its Nevada and Idaho exploration assets. An interesting angle is how stronger gold prices can make mine-construction financing more attainable, potentially accelerating timelines for turning U.S.-based mineral resources into producing...
NYSE:DX
NYSE:DXMortgage REITs

Dynex Capital (DX) Dividend Strain Challenges Bullish Reaction To FY 2025 Earnings Rebound

Dynex Capital (DX) has wrapped up FY 2025 with Q4 total revenue of US$202.0 million and basic EPS of US$1.17, alongside trailing twelve month revenue of US$372.1 million and EPS of US$2.49. This sits next to a very large 190.8% earnings jump over the past year and an 11.4% annual earnings decline over five years. The company has seen quarterly revenue move from US$60.3 million in Q4 2024 to US$201.997 million in Q4 2025, while basic EPS shifted from US$0.61 to US$1.17 over the same period...
NasdaqCM:KARO
NasdaqCM:KAROSoftware

Is It Too Late To Consider Karooooo (KARO) After Its Strong Share Price Run?

After a strong run, you might be wondering whether Karooooo is still reasonably priced or starting to look stretched at current levels. The stock last closed at US$50.84, with returns of 8.6% over the past week, 7.3% over the last month, 13.8% year to date, and 19.6% over the past year. This puts recent price action front and center for anyone thinking about value. Over the past three years, Karooooo has delivered a total return of 122.8%, which gives useful context to the shorter term moves...
NasdaqGS:CLOV
NasdaqGS:CLOVHealthcare

Clover Health Balances Customer Growth And Cash Flow Against Revenue Pressure

Clover Health Investments (NasdaqGS:CLOV) is reporting strong customer growth for its Medicare Advantage plans and related technology solutions. The company is seeing an expanding free cash flow margin even as revenue has declined over the past two years. This mix of higher customer counts and improving cash generation, alongside revenue pressure, is a fresh development that investors are assessing. Clover Health focuses on Medicare Advantage insurance and technology driven care tools,...
NasdaqGM:ALT
NasdaqGM:ALTBiotechs

Altimmune (ALT) Valuation Check After Pemvidutide’s FDA Breakthrough Therapy Designation

FDA Breakthrough designation puts pemvidutide in focus Altimmune (ALT) has drawn fresh attention after the FDA granted Breakthrough Therapy Designation to its lead candidate pemvidutide for MASH, based on mid stage trial data showing significant disease resolution. See our latest analysis for Altimmune. The FDA Breakthrough Therapy news has arrived during a period of building momentum for Altimmune, with the 7 day share price return of 33.49% and year to date share price return of 61.25%...
NYSE:SM
NYSE:SMOil and Gas

Is SM Energy’s (SM) Cheaper Valuation Offsetting Its Weaker Earnings Outlook?

SM Energy recently drew attention after Zacks assigned it a Rank #5 (Strong Sell), following a decline in consensus earnings estimates that raised questions about its near-term earnings outlook. At the same time, SM Energy’s shares are trading at a discount to peers, creating an unusual mix of weaker earnings expectations and apparently cheaper valuation. With this context in mind, we’ll explore how weaker earnings estimates may influence SM Energy’s investment narrative for investors. The...
NYSE:SGHC
NYSE:SGHCHospitality

Super Group Special Dividend Highlights Confidence In Growth And Cash Flows

Super Group (NYSE:SGHC) declared a special dividend following its full year results, highlighting management’s confidence in the business. The payout comes after the company reported strong performance for the year and record highs in active customers and deposits. The decision adds a shareholder income component on top of Super Group’s existing online sports betting and gaming operations. Super Group, which operates online sports betting and gaming brands, is leaning on a growing base of...
NYSE:HTGC
NYSE:HTGCCapital Markets

Is Hercules Capital (HTGC) Attractively Priced After Recent Share Price Pullback?

If you are wondering whether Hercules Capital is priced attractively right now, you are not alone. Many investors are asking if the current share price lines up with the underlying value. The stock recently closed at US$18.56, with returns of a 1.9% decline over 7 days, a 0.7% decline over 30 days, a 1.6% decline year to date, a 1.6% decline over 1 year and gains of 81.8% over 3 years and 111.6% over 5 years. This naturally raises questions about what is already baked into the price. Recent...
NasdaqGS:HBT
NasdaqGS:HBTBanks

HBT Financial (HBT) Net Interest Margin Stability Reinforces Bullish Profitability Narratives

HBT Financial (HBT) has wrapped up FY 2025 with fourth quarter revenue of US$59.0 million and basic EPS of US$0.60, while trailing twelve month revenue came in at US$233.9 million and EPS at US$2.44. Over the last few quarters, the company has seen revenue range from US$55.8 million to US$59.2 million per quarter, with quarterly EPS between US$0.58 and US$0.64, giving investors a consistent earnings profile to judge against prior periods. With trailing net profit margins holding in the low...
NasdaqGS:STLD
NasdaqGS:STLDMetals and Mining

Steel Dynamics (STLD) Margin Compression To 6.5% Tests Bullish Earnings Growth Narrative

Steel Dynamics (STLD) has wrapped up FY 2025 with fourth quarter revenue of US$4.4 billion and basic EPS of US$1.83, as the market weighs those figures against a current share price of US$173.32. The company has seen quarterly revenue move from US$3,872 million in Q4 2024 to US$4,414 million in Q4 2025, while basic EPS over that same period shifted from US$1.36 to US$1.83. This is setting the stage for investors to focus closely on how net income trends and margins color the latest set of...
NYSE:FIGS
NYSE:FIGSLuxury

Is FIGS (FIGS) Still Sensibly Priced After A 96% One Year Share Price Surge

If you are wondering whether FIGS at US$11.26 is still attractively priced after its recent run, this article walks through what the numbers are saying about its current value. The stock has delivered a 96.9% return over the last year and 33.6% over three years, even though the past week and month saw returns of 2.9% decline and 4.7% decline, with a 1.1% decline year to date. Recent attention on FIGS has centered on its position in medical apparel and how the brand is competing in a crowded...
NasdaqGM:ASST
NasdaqGM:ASSTCapital Markets

Assessing Strive Asset Management’s Valuation After Recent Share Price Weakness And Ongoing Losses

Why Strive Asset Management (ASST) Is Back on Investors’ Radar Strive Asset Management (ASST) has caught investor attention after recent trading, with the share price closing at US$0.79 and short term returns showing mixed results over the past week and month. For you as an investor, the sharper move over the past 3 months, along with a value score of 2 and reported revenue of US$5.51 million against a net loss of US$223.39 million, raises clear questions about risk, valuation and business...
NasdaqCM:HBNB
NasdaqCM:HBNBReal Estate

Hotel101 Weighs Melbourne Flagship And US$300m Raise Against Cash Needs

Hotel101 Global Holdings, NasdaqCM:HBNB, has entered binding agreements to develop a 766 room hotel in Melbourne's central business district. The company plans to raise up to US$300 million through a perpetual convertible preferred share offering approved by its board. The Melbourne project and capital raise are intended to support Hotel101's move toward operating in 100 countries with its standardized condotel model. Hotel101 Global Holdings focuses on a standardized condotel concept,...
OTCPK:FMBL
OTCPK:FMBLBanks

Farmers & Merchants Bank (OTCPK:FMBL) Margin Improvement Challenges Bearish Profitability Narratives

Farmers & Merchants Bank of Long Beach (FMBL) has capped FY 2025 with fourth quarter total revenue of US$79.1 million, basic EPS of US$159.97 and net income of US$19.5 million. Trailing twelve month EPS reached US$559.71 on revenue of US$293.2 million and net income of US$68.3 million. Over recent quarters the bank has seen revenue move from US$56.6 million in Q4 2024 to US$79.1 million in Q4 2025, with basic EPS increasing from US$32.46 to US$159.97 over the same span. This has set up a...